Top Markets
Coin of the day
Evgen Pharma plc Evgen Pharma plc

Evgen Pharma plc

EVG
Rankning i aktier #38016
Evgen Pharma plc, a UK-based pharmaceutical company founded in 2014, operates... Evgen Pharma plc, a UK-based pharmaceutical company founded in 2014, operates at the clinical development stage, concentrating on the creation of sulforaphane-based medications. Its mission is to combat various cancers and inflammatory conditions. The firm utilizes its proprietary Sulforadex technology, which is engineered to stabilize sulforaphane, in its product development. SFX-01 stands as their principal drug candidate, currently in Phase II clinical trials for metastatic breast cancer and Phase Ib/IIa trials for glioblastoma. Furthermore, SFX-01 is being investigated in preclinical stages for haematological malignancies and analogous disorders. The company also offers out-licensing services for its innovative technology.
Aktiekurs
$0.00953895
Senast synkroniserad: 2024-05-22
Marknadsvärde
$1.28M
Förändring (1 dag)
0.06%
Förändring (1 år)
0.00%
Land
GB
Handel Evgen Pharma plc (EVG)

Kategori

Historik för aktiesplit för Evgen Pharma plc (EVG)
Aktien Evgen Pharma plc (symbol: EVG) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 15, 2026.
En EVG-aktie köpt före Aug 15, 2026 motsvarar nu 0 EVG-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE